Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-665-4 | CAS number: 68308-74-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11 December 2012 to 23 January 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study conducted according to relevant guidelines, with no deviations.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- The animals were nulliparous and non-pregnant female CBA/Ca (CBA/CaOlaHsd) mice, supplied by Harlan Laboratories UK Ltd. The animals were acclimatised for at least 5 days, and randomly allocated to treatment groups. At the start of the study the mice weighed 15 to 23 g and were 8 to 12 weeks old. They were individually housed in suspended solid floor polypropylene cages furnished with softwood woodflakes. Mains tap water and food (2014C Teklad Global Rodent diet) were provided ad libitum. Temperature was maintained as 19 to 25°C and relative humidity at 30 to 70%. Lighting was provided on a 12 hour cycle, and there were approximately 15 air changes per hour.
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Preliminary test: 25%, 50% or 100% v/v in acetone/olive oil 4:1
Main test: 0%, 5%, 10% or 25% v/v in acetone/olive oil 4:1 - No. of animals per dose:
- Preliminary test: 1 mouse/dose
Main test: 4 mice/dose - Details on study design:
- The test material was freshly prepared as a solution in acetone/olive oil 4:1. The test material was formulated within two hours of being applied to the test system, it was assumed that the formulation was stable for this duration.
A preliminary screening test was performed using three mice (one mouse per concentration), The mice were treated by daily application of 25 µL of either undiluted test material, or concentrations of 50% or 25% v/v in acetone/olive oil 4:1 to the dorsal surface of each ear for three consecutive days (Days 1, 2 3). The mice were observed twice daily on Days 1, 2 and 3 and once daily on Days 4, 5 and 6. Local skin irritation was scored daily. Any clinical signs of toxicity were recorded. Bodyweights were recorded on Day 1 (prior to dosing) and on Day 6. The thickness of each ear was measured using an Oditest micrometer, pre-dose on Day 1, post-dose on Day 3 and on Day 6. Any changes in ear thickness were noted. Mean ear thickness changes were calculated between time periods Day 1 and 3 and Days 1 and 6. A mean ear thickness increase of equal to or greater than 25% was considered to indicate excessive irritation.
In the main test, groups of four mice were treated with the test material at concentrations of 5%, 10% or 25% v/v in acetone/olive oil 4:1. The preliminary screening test suggested that there would be no systemic toxicity or excessive local irritation at a concentration of 25%. The mice were treated by daily application of 25 µL of the appropriate concentration to the dorsal surface of the ear for three consecutive days (Days 1, 2, 3). The controls received the vehicle alone in the same manner. Five days following the first topical application (Day 6) all mice were injected via the tail vein with 250 µL of phosphate buffered saline (PBS) containing 3H methyl thymidine (3HTdR: 80 µCi/mL, specific activity 2.0 Ci/mmol) giving a total of 20 µCi to each mouse.
Clinical observations were made twice daily on Days 1, 2 and 3 and on a daily basis on Days 4, 5 and 6. Bodyweights were recorded on Day 1 (prior to dosing) and Day 6 (prior to termination).
Five hours following the administration of 3HTdR all mice were killed. The draining auricular lymph nodes from the four mice were excised and pooled for each experimental group. For each group 1 mL of PBS was added to the pooled lymph nodes. A single cell suspension of pooled lymph node cells was prepared by gentle mechanical disaggregation through a 200-mesh stainless steel gauze. The cells were rinsed through the gauze with 4 mL of PBS into a petri dish. The cell suspension was transferred to a centrifuge tube, the petri dish was washed with an additional 5 mL of PBS and the washings added to the tube. The cells were pelleted at 1400 rpm for 10 minutes. The pellet was resuspended in 10 mL of PBS and re-pelleted. To precipitate out the radioactive material, the pellet was resuspended in 10 mL of PBS and re-pelleted. To precipitate out the radioactive material, the pellet was resuspended in 3 mL of 5% trichloroacetic acid (TCA). After approximately 18 hours incubation at ca. 4°C, the precipitates were removed by centrifugation at 2100 rpm for 10 minutes, resuspended in 1 mL of TCA and transferred to 10 mL of scintillation fluid. 3HTdR incorporation was measured by scintillation counting. The vials were placed in the sample changer and left for approximately 20 minutes in the dark, to reduce the risk of luminescence. The vials were shaken vigorously afterwards. The number of radioactive disintegrations per minute was then measured.
The proliferation response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph node (disintegrations/minute/node) and as the ratio of 3HTdR incorporation into lymph node cells of test nodes relative to that recorded for the control nodes (Stimulation Index). Test materials causing a threefold or greater increase in 3HTdR incorporation in at least once concentration compared to control values are regarded as sensitisers. The EC3 value was also calculated using the following equation: EC3 = c + [[(3-d)/(b-d)] x (a-c)] where a is the lowest concentration giving a stimulation index > 3, b is the actual stimulation index caused by 'a', c is the highest concentration failing to produce a stimulation index of 3 and d is the actual stimulation index caused by 'c'. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Not required.
- Positive control results:
- In a separate study, a group of 5 mice were treated with alpha-Hexylcinnamaldehyde, tech., 85% at a concentration of 25% v/v in acetone/olive oil 4:1. Controls received the vehicle alone. The Stimulation Index was 6.29 therefore alpha-Hexylcinnamaldehyde, tech., 85% was considered to be a skin sensitiser.
- Parameter:
- SI
- Remarks on result:
- other: Stimulation indices of 1.09, 3.40 and 7.19 was obtained for test material concentrations of 5%, 10% and 25%, respectively.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: DPM values were 10345.17, 11283.55, 35150.61 and 74432.01 for concentrations of 0%, 5%, 10% and 25%.
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The EC3 value was calculated to be 9.13%. The test material was considered to be a skin sensitiser under the conditions of the test.
- Executive summary:
The skin sensitisation potential of DMATO was evaluated in the Local Lymph Node Assay (LLNA) according to OECD Guideline 429 and GLP. Groups of four female CBA/Ca mice were treated with the test material at concentrations of 5%, 10% or 25% v/v in acetone/olive oil 4:1. Controls received the vehicle alone. The highest dose selected for the main study was chosen following a preliminary screening test in which no clinical signs of toxicity were noted at a concentration of 25%. The test material formulations were applied to the dorsum of each ear for 3 consecutive days. The draining auricular lymph nodes were harvested on Day 6, following administration of 3 -HTdR, and incorporation of 3 -HTdR was measured using scintillation counting. The Stimulation Index was expressed as the mean radioactive incorporation for each treatment group, divided by the mean radioactive incorporation of the vehicle controls group; values of greater than or equal to 3.0 indicate a positive result. The Stimulation Indices were 1.09, 3.40 and 7.19 for test concentrations 5%, 10% and 25%, respectively. The concentration expected to cause a 3 fold increase in 3HTdR incorporation (EC3 value) was calculated to be 9.13%. The test material was considered to be a skin sensitiser under the conditions of the test, and requires classification as a Category 1B Skin Sensitiser according to Regulation (EC) No 1272/2008.
Reference
There were no deaths, and no signs of systemic toxicity were noted in the test or control animals during the main test. Bodyweight changes between Days 1 and 6 were comparable to those observed in the corresponding control group over the same period.
Table 1. Results obtained in the main LLNA study
Concentration (% v/v) in acetone/olive oil 4:1 |
dpm |
dpm/Nodea |
Stimulation Indexb |
Result |
Vehicle |
10345.17 |
1293.15 |
1.00 |
Negative |
5 |
11283.55 |
1410.44 |
1.09 |
negative |
10 |
35150.61 |
4393.83 |
3.40 |
positive |
25 |
74432.01 |
9304.00 |
7.19 |
positive |
dpm = disintegrations per minute
a = disintegrations per minute/node
b = Stimulation Index of 3.0 or greater indicates a positive result
na = not applicable
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
The skin sensitisation potential of DMATO was evaluated in the Local Lymph Node Assay (LLNA) according to OECD Guideline 429 and GLP. Groups of four female CBA/Ca mice were treated with the test material at concentrations of 5%, 10% or 25% v/v in acetone/olive oil 4:1. Controls received the vehicle alone. The highest dose selected for the main study was chosen following a preliminary screening test in which no clinical signs of toxicity were noted at a concentration of 25%. The test material formulations were applied to the dorsum of each ear for 3 consecutive days. The draining auricular lymph nodes were harvested on Day 6, following administration of 3 -HTdR, and incorporation of 3 -HTdR was measured using scintillation counting. The Stimulation Index was expressed as the mean radioactive incorporation for each treatment group, divided by the mean radioactive incorporation of the vehicle controls group; values of greater than or equal to 3.0 indicate a positive result. The Stimulation Indices were 1.09, 3.40 and 7.19 for test concentrations 5%, 10% and 25%, respectively. The concentration expected to cause a 3 fold increase in 3HTdR incorporation (EC3 value) was calculated to be 9.13%. The test material was considered to be a skin sensitiser under the conditions of the test, and requires classification as a Category 1B Skin Sensitiser according to Regulation (EC) No 1272/2008.
Migrated from Short description of key information:
A modern, guideline-compliant mouse LLNA is available for the submission substance.
Justification for selection of skin sensitisation endpoint:
Only study available for this endpoint
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the results of the available mouse LLNA (EC3 = 9.13%); DMATO requires classification as a Category 1B Skin Sensitiser according to Regulation (EC) No 1272/2008. Classification with (R43) 'May cause sensitisation by skin contact' is appropriate according to Directive 67/548/EEC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.